Back to AKRE CAPITAL MANAGEMENT LLC

SOPH
Showing 8 of 9 quarters

Position history for AKRE CAPITAL MANAGEMENT LLC's holdings in SOPHIA GENETICS SA CHF0.05 Common Stock

AKRE CAPITAL MANAGEMENT LLC holds 3.7M shares of SOPH (SOPHIA GENETICS SA CHF0.05 Common Stock), worth $18.4M as of 2026-Q1. SOPH represents 0.3% of AKRE CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$18.4M

Current Shares

3.7M

Total Value Change

+$9.6M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
3.7M
0.0%
$18.4M0.3%$4.10
0
2025-Q4
Unchanged
3.7M
0.0%
$17.4M0.2%$4.73
0
2025-Q3
Unchanged
3.7M
0.0%
$17.7M0.2%$4.43
0
2025-Q2
Increased
3.7M
+66.2%
$11.5M0.1%$3.09
52
2025-Q1
Unchanged
2.2M
0.0%
$7.4M0.1%$3.26
0
2024-Q4
Unchanged
2.2M
0.0%
$6.9M0.1%$3.11
0
2024-Q3
Increased
2.2M
+16.5%
$8.2M0.1%$3.73
35
2024-Q2
Increased
1.9M
+567.5%
$8.8M0.1%$4.58
47

Other major holders of SOPH: GENERATION INVESTMENT MANAGEMENT LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used